AR016827A1 - A process for preparing a tablet PHARMACEUTICAL - Google Patents

A process for preparing a tablet PHARMACEUTICAL

Info

Publication number
AR016827A1
AR016827A1 ARP980104077A AR016827A1 AR 016827 A1 AR016827 A1 AR 016827A1 AR P980104077 A ARP980104077 A AR P980104077A AR 016827 A1 AR016827 A1 AR 016827A1
Authority
AR
Argentina
Prior art keywords
process
tablet
preparing
tablet pharmaceutical
mixture
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US5689997P priority Critical
Priority to US8164498P priority
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR016827A1 publication Critical patent/AR016827A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Abstract

Una tableta rápidamente desintegrable para administracion por vía oral, que comprende una mezcla compactada de metilcelulosa que tiene una viscosidad de>1.000 centipoises, y un diluyente seleccionado entre celulosa microcristalina, almidon de maíz,S tarch 1500, o una mezcla de ellos, y procedimiento para lapreparacion de una formulacion de tableta y un procedimiento para la fabricacion de una tableta farmacéutica. A tablet rapidly disintegrable for oral administration comprising a compacted methylcellulose mixture having a viscosity of> 1000 centipoises, and a diluent selected from microcrystalline cellulose, corn starch, S TARCH 1500, or a mixture thereof, and procedure lapreparacion for a tablet formulation and process for the manufacture of a pharmaceutical tablet.
ARP980104077 1997-08-22 1998-08-18 A process for preparing a tablet PHARMACEUTICAL AR016827A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US5689997P true 1997-08-22 1997-08-22
US8164498P true 1998-04-14 1998-04-14

Publications (1)

Publication Number Publication Date
AR016827A1 true AR016827A1 (en) 2001-08-01

Family

ID=26735830

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980104077 AR016827A1 (en) 1997-08-22 1998-08-18 A process for preparing a tablet PHARMACEUTICAL
ARP050102043A AR049055A2 (en) 1997-08-22 2005-05-18 A rapidly disintegrating tablet for oral administration
ARP050102065A AR049057A2 (en) 1997-08-22 2005-05-19 A rapidly disintegrating tablet for oral administration

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP050102043A AR049055A2 (en) 1997-08-22 2005-05-18 A rapidly disintegrating tablet for oral administration
ARP050102065A AR049057A2 (en) 1997-08-22 2005-05-19 A rapidly disintegrating tablet for oral administration

Country Status (17)

Country Link
US (2) US6372253B1 (en)
EP (1) EP1014949A4 (en)
JP (1) JP2001513546A (en)
KR (1) KR20010023198A (en)
CN (1) CN1240374C (en)
AR (3) AR016827A1 (en)
AU (1) AU745682B2 (en)
BR (1) BR9811987A (en)
CA (1) CA2301132C (en)
CO (1) CO4960646A1 (en)
EA (1) EA003663B1 (en)
HU (1) HU0003186A3 (en)
MY (1) MY137768A (en)
NZ (1) NZ502890A (en)
PL (1) PL338786A1 (en)
TW (1) TWI228421B (en)
WO (1) WO1999009959A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
AR017512A1 (en) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Methylcellulose rapidly disintegrating tablets for oral administration and process for preparing them
AR016827A1 (en) * 1997-08-22 2001-08-01 Smithkline Beecham Corp A process for preparing a tablet PHARMACEUTICAL
US6348264B1 (en) 1998-04-27 2002-02-19 Roquette Freres Process for producing low de starch hydrolysates by nanofiltration fractionation, products obtained thereby, and use of such products
AU745697B2 (en) * 1998-09-08 2002-03-28 Smithkline Beecham Corporation Lipstatin derivative-soluble fiber tablets
DE50001734D1 (en) * 2000-10-24 2003-05-15 Fit Gmbh Coprozessiertes granular disintegrant
SK287988B6 (en) * 2001-01-26 2012-09-03 Schering Corporation Composition, oral dosage form and use thereof
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
EP2402010A1 (en) 2002-12-16 2012-01-04 Kissei Pharmaceutical Co., Ltd. Solid drug for oral use
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
EP1695699A4 (en) 2003-12-09 2012-08-22 Dainippon Sumitomo Pharma Co Drug-containing grains and solid preparation containing the grains
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
MX2007004741A (en) * 2004-10-21 2007-09-07 Eurand Pharmaceuticals Ltd Taste-masked pharmaceutical compositions with gastrosoluble pore-formers.
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
JP2008534498A (en) * 2005-03-23 2008-08-28 ビーピーエスアイ ホールディングス,エルエルシー. Aggregate starch composition
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
RS54258B1 (en) * 2005-05-05 2016-02-29 Bristol-Myers Squibb Holdings Ireland Formulations of a src/abl inhibitor
CA2617051C (en) * 2005-07-29 2013-12-17 Stichting Groningen Centre For Drug Research Ph-controlled pulsatile delivery system, methods for preparation and use thereof
PE06982007A1 (en) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Intraoral quick disintegrating tablet containing ambroxol hydrochloride
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
ES2403032T3 (en) 2006-11-07 2013-05-13 The Procter & Gamble Company Fiber compositions containing and methods of manufacture and use thereof
CL2008000280A1 (en) 2007-02-01 2008-08-18 Takeda Pharmaceutical pharmaceutical composition in tablet form comprising a granule comprising an active substance which induces a problem easily compression and microcrystalline cellulose compression aid and containing magnesium stearate and
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US8420700B1 (en) * 2008-06-04 2013-04-16 James M. Bausch Tamper resistant lipid-based oral dosage form for sympathomimetic amines
US8273798B2 (en) * 2007-06-04 2012-09-25 Shear Kershman Laboratories Tamper resistant lipid-based oral dosage form for opioid agonists
DE102008037324A1 (en) * 2008-08-11 2010-02-18 Ratiopharm Gmbh A pharmaceutical formulation for pulmonary blood pressure lowering
CN102215677B (en) 2008-11-17 2014-07-16 巴斯夫欧洲公司 Starch-containing granular formulation
EP2506836B1 (en) 2009-12-02 2018-02-14 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
TWI564008B (en) 2010-09-30 2017-01-01 Shionogi & Co Formulation for solubility enhancement of poorly soluble drugs
US9675551B2 (en) * 2011-10-25 2017-06-13 Expermed S.A. Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
CN104797244B (en) 2012-07-27 2018-03-09 红山生物医药有限公司 Formulations and formulation methods for preparing the colon evacuation

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3402240A (en) 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
US3147187A (en) 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3622673A (en) 1968-11-14 1971-11-23 Upjohn Co 4-(1,4,5,6-TETRAHYDROZEPINO 4,5-b INDOL-3(2H)-YL-BUTYROPHENON COMPOSITIONS AND PROCESS OF TREATMENT MENTAL OR EMOTIONAL DISORDERS
DE1931910B2 (en) 1969-06-24 1974-11-28 Boehringer Mannheim Gmbh, 6800 Mannheim
US3969504A (en) 1975-02-14 1976-07-13 The Upjohn Co. 6-Phenyl benzodiazepine antidepressants
US4048331A (en) 1974-10-15 1977-09-13 The Upjohn Company Process of treatment
US3961056A (en) 1974-02-11 1976-06-01 The Upjohn Company Substituted morpholine guanidines for the treatment of arrhythmic conditions
US3968211A (en) 1974-02-11 1976-07-06 The Upjohn Company Compositions and methods of use of amidines for anti-arrhythmic purposes
JPS5438167B2 (en) * 1974-04-27 1979-11-19
US4148878A (en) 1977-12-23 1979-04-10 Nelson Research & Development Company Inhibition of platelet aggregation with selected phosphoric acid esters
US4148879A (en) 1977-12-23 1979-04-10 Nelson Research & Development Company Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters
US4327080A (en) 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS58144316A (en) 1982-02-18 1983-08-27 Chiyoda Yakuhin Kk Stable indomethacin tablet
US4508726A (en) 1982-09-16 1985-04-02 The Upjohn Company Treatment of panic disorders with alprazolam
ZA8401044B (en) 1983-02-17 1984-09-26 Merrell Dow Pharma Dry mix cellulose ether compositions as bulk laxatives
US4517179A (en) 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
JPS6028915A (en) 1983-07-26 1985-02-14 Eisai Co Ltd Composition containing large amount of ubidecarenone
US4476134A (en) 1983-08-01 1984-10-09 The Upjohn Company Process for treating panic disorders
SE8601624D0 (en) 1986-04-11 1986-04-11 Haessle Ab New Pharmaceutical Preparations
IT1200178B (en) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Galenic formulations with programmed release containing drugs to attivita 'antiphlogistic
JPH0618774B2 (en) 1986-10-09 1994-03-16 塩野義製薬株式会社 Method for producing a sugar-coated tablets
AU8325987A (en) 1986-12-11 1988-06-30 Upjohn Company, The Antipsychotic amino-polyhydro-benz-(iso)quinolines and intermediates
JPS63222112A (en) 1987-03-10 1988-09-16 Nippon Soda Co Ltd Sustained release granule
JPS63280023A (en) 1987-05-11 1988-11-17 Yoshitomi Pharmaceut Ind Ltd Antirheumatic
NO883326L (en) 1987-08-11 1989-02-13 Bayer Ag DHP-retard preparation.
JPH01168619A (en) 1987-12-24 1989-07-04 Takada Seiyaku Kk Novel acetic acid chlormadinone solid preparation
US4866046A (en) 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
US5292520A (en) 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
AT113202T (en) 1990-11-29 1994-11-15 Wei Ming Pharmaceutical Mfg Co Subcarrier for direct compression.
JPH0515319A (en) 1990-12-14 1993-01-26 Sunstar Inc Method for dispersing sparingly water-soluble salts and drinking composition containing the same dispersed therein
US5403593A (en) * 1991-03-04 1995-04-04 Sandoz Ltd. Melt granulated compositions for preparing sustained release dosage forms
JPH05139973A (en) 1991-11-20 1993-06-08 Shin Etsu Chem Co Ltd Production of nifedipin-containing solid preparation
US5534262A (en) 1992-01-10 1996-07-09 Dobrotvorsky; Anatoly E. Pharmaceutical granulated composition and method for preparing same
AU665690B2 (en) * 1992-05-08 1996-01-11 Otsuka Pharmaceutical Factory, Inc. Indole derivative
IT1255522B (en) 1992-09-24 1995-11-09 Ubaldo Conte Tablet for therapeutic use capable of releasing one or more 'active substances with different speed'
DE4333190C2 (en) 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette with delayed-release
US5496884A (en) 1993-11-12 1996-03-05 Lord Corporation Aqueous adhesive for bonding elastomers
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
JPH07267850A (en) 1994-03-28 1995-10-17 Eisai Co Ltd Medicine composition prevented in unpleasant taste and method for producing the same
US5543099A (en) 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
AR016827A1 (en) * 1997-08-22 2001-08-01 Smithkline Beecham Corp A process for preparing a tablet PHARMACEUTICAL
AR017512A1 (en) 1997-08-22 2001-09-12 Smithkline Beecham Corp Methylcellulose rapidly disintegrating tablets for oral administration and process for preparing them

Also Published As

Publication number Publication date
AR049055A2 (en) 2006-06-21
EP1014949A1 (en) 2000-07-05
HU0003186A3 (en) 2001-04-28
AU745682B2 (en) 2002-03-28
CA2301132C (en) 2007-11-13
WO1999009959A1 (en) 1999-03-04
KR20010023198A (en) 2001-03-26
US20030049315A1 (en) 2003-03-13
US6372253B1 (en) 2002-04-16
CN1276718A (en) 2000-12-13
CO4960646A1 (en) 2000-09-25
AR049057A2 (en) 2006-06-21
BR9811987A (en) 2000-09-05
NZ502890A (en) 2002-03-01
EA200000245A1 (en) 2000-08-28
MY137768A (en) 2009-03-31
US7132114B2 (en) 2006-11-07
CA2301132A1 (en) 1999-03-04
HU0003186A2 (en) 2001-02-28
CN1240374C (en) 2006-02-08
TWI228421B (en) 2005-03-01
AU9114698A (en) 1999-03-16
EA003663B1 (en) 2003-08-28
JP2001513546A (en) 2001-09-04
PL338786A1 (en) 2000-11-20
EP1014949A4 (en) 2006-06-21

Similar Documents

Publication Publication Date Title
RU2217145C2 (en) Heteroarylalkenyl derivatives of cyclopentaneheptan(en)oic acid
RU2227022C2 (en) Bioadhesive buccal sustained-release tablet
DE60142891D1 (en) Azetidine derivatives containing pharmaceutical compositions comprising azetidine derivatives and their preparation
NO323142B1 (en) Trans-olefinic glycokinase activators, their use as medicaments, pharmaceutical compositions containing them, their use for the manufacture of a medicament for the treatment or prevention of Type II diabetes as well as process feed for the preparation thereof.
NO325280B1 (en) Pyrimidine derivatives, process feed for the preparation thereof, pharmaceutical compositions containing such, such compounds for use as a medicament and the use of such compounds for the manufacture of a medicament for the treatment of diseases
HU9802694A3 (en) Benzamide derivatives, process for producing them and pharmaceutical compositions containing them
NO330947B1 (en) The use of pharmaceutical compositions containing oxcarbazepine, in fasting conditions
AR012717A1 (en) Trihydrate of magnesium salt of s-omeprazole, a process for their preparation, pharmaceutical composition and use of said trihydrate for making medicines.
RU98104448A (en) Oral compositions of dopamine agonists bystrorastvoryayuschiesya
ES2042541T3 (en) A method of preparing a pharmaceutical delayed release formulation containing xanthan gum.
DE69006365T2 (en) Uncoated pharmaceutical tablet reaction.
PE57599A1 (en) Compositions containing tetrahydrolipstatin
NO970507D0 (en) Composition for delivering drugs through the mucosa
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
NO326196B1 (en) 5-alkyl-2-arylaminofenyleddiksyrer and salts or esters thereof, their use, pharmaceutical compositions and methods of preparing the compounds.
AT113481T (en) Immunoconjugates and prodrugs and their common application for the administration of medicines.
NO322898B1 (en) Use of GLP-1, GLP-1 analogues or GLP-1 derivatives and salts thereof for preparing a pharmaceutical composition for the treatment of acute myocardial infarction.
NO331739B1 (en) The compressed solid oral dosage forms of valsartan and hydrochlorothiazide
RU96123129A (en) Derivatives of erythromycin, the process for their preparation and their use as medicaments
NO325177B1 (en) Pyrimidine compounds, process feed for the preparation thereof, pharmaceutical compositions comprising such, such compounds as medicaments and their use in such manufacture of a medicament for the treatment of disease
KR950013501A (en) Insoluble i.e. oral sustained release tablet comprising an immediate release tablet core of the drug with a sustained release coating material
NO973840L (en) A dosage form for delivering an active agent
ID22973A (en) The pharmaceutical composition of oral administration of the derivative n-piperidino-3-pirazolkarboksamida, and salts thereof
RU97114938A (en) Substituted heterocyclic compounds, a method for preparing said compounds and pharmaceutical compositions containing them
HU9802422A3 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FB Suspension of granting procedure